“DBT-BIRAC has facilitated the establishment of the first-of-its-kind mRNA-based vaccine manufacturing platform in India. DBT has provided seed funding for the development of Gennova’s novel self-amplifying mRNA-based vaccine candidate for COVID-19, the DBT had said in a statement earlier.

Apollo Hospitals has so far trained 6,000 staff to give out jabs across its network of 71 hospitals, hundreds of clinics and thousands of pharmacies, according to Managing Director Suneeta Reddy, who said the company’s talks with officials in New Delhi had yet to provide any firm guidance.

“We need to know if the government wants to handle the whole thing or allow the private sector to do it,” Reddy said in an interview Tuesday.

“The issue here is how can we double the amount of people that can be vaccinated,” she said from Chennai, adding that Apollo is ready to help in any capacity. The government “can do it, but it will take time.”

The number of people who have recuperated from the disease surged to 92,15,581, pushing the national recovery rate to 94.66 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent.

There are 3,78,909 active coronavirus infections in the country now which comprises 3.89 per cent of the total caseload, the data stated.
The COVID-19 active caseload remained below four lakh for the third consecutive day.